Insider Transactions in Q3 2022 at Caribou Biosciences, Inc. (CRBU)
Insider Transaction List (Q3 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 15
2022
|
Barbara G Mcclung Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
27,595
+3.42%
|
$55,190
$2.69 P/Share
|
Aug 25
2022
|
Steven Kanner Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
43,248
-12.52%
|
$475,728
$11.22 P/Share
|
Aug 25
2022
|
Steven Kanner Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
43,248
+11.13%
|
$86,496
$2.69 P/Share
|
Aug 22
2022
|
Ryan Fischesser VP of Finance and Controller |
BUY
Grant, award, or other acquisition
|
Direct |
4,848
+3.87%
|
-
|